SCHEDULE: Laurence W. Lytton & Foundation Report IN8BIO Stake

Laurence W. Lytton and the Lytton-Kambara Foundation have jointly filed a Schedule 13G, reporting a combined 9.99% beneficial ownership in IN8BIO, Inc.

Summary

• Laurence W. Lytton and the Lytton-Kambara Foundation have filed an amended Schedule 13G, indicating their beneficial ownership of IN8BIO, Inc. common stock.
• The filing reports a combined beneficial ownership of 1,056,513 shares, representing 9.99% of the class of securities.
• This ownership includes 327,892 shares of common stock and warrants to purchase 1,092,753 shares of common stock, subject to a 9.99% beneficial ownership limitation.
• The percentage of class is calculated based on 9,847,089 shares of common stock outstanding as of May 4, 2026, as reported in the company's Form 10-Q for the quarter ended March 31, 2026.
• Both reporting persons have shared voting power and shared dispositive power over the reported shares.
• An agreement regarding joint filing of Schedule 13D or 13G statements has been executed by Laurence W. Lytton and the Lytton-Kambara Foundation.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting ownership stakes and not containing operational or financial performance updates.

Positives

• The filing clearly defines the beneficial ownership stake of Laurence W. Lytton and the Lytton-Kambara Foundation.
• The joint filing agreement ensures coordinated reporting of ownership changes.

Negatives

• The filing does not provide any information on the company's operational performance, financial health, or future prospects.

Risks

• The beneficial ownership is subject to a 9.99% limitation, implying potential adjustments if ownership exceeds this threshold.
• The filing does not detail the specific terms or exercise conditions of the warrants held.

Future Outlook

No forward-looking statements or guidance are provided in this filing, as it pertains to ownership reporting.

Management Comments

• Laurence W. Lytton and the Lytton-Kambara Foundation agree to jointly file any and all statements on Schedule 13D or Schedule 13G.
• Laurence W. Lytton is appointed as the agent and attorney-in-fact for preparing, signing, and filing necessary documents with the SEC.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant individual shareholders to report their stakes in public companies, indicating a substantial, but not controlling, interest.

Corporate Governance

Stakeholder Impact

• Shareholders: The filing provides transparency regarding significant beneficial ownership, which can influence market perception and trading activity.
• Management: The reporting persons' stake may signal their interest in the company's performance and governance.

Next Steps

• The reporting persons will continue to monitor their beneficial ownership in IN8BIO, Inc.
• Any future changes in beneficial ownership may require further filings with the SEC.

Key Dates

Keywords

IN8BIO, Schedule 13G, Beneficial Ownership, Laurence W. Lytton, Lytton-Kambara Foundation, Warrants, Joint Filing Agreement